Belzutifan (WELIREG) – Uses, Dosage & Brands in UAE

About Belzutifan

Class: | Antineoplastic agent, Hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor Use: | Treatment of adults with von Hippel-Lindau (VHL) disease-associated renal cell carcinoma (RCC) not requiring immediate surgery Adult dose: | 120 mg orally once daily, taken with or without food Pediatric dose: | Safety and efficacy not established in pediatric patients Side effects: | Fatigue, nausea, diarrhea, headache, hypertension, anemia Contraindications: | Hypersensitivity to belzutifan or a

Drug Class

Antineoplastic agent, Hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor

Uses & Indications

Treatment of adults with von Hippel-Lindau (VHL) disease-associated renal cell carcinoma (RCC) not requiring immediate surgery

Storage Requirements

Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F)

Manufacturer & Packaging

Manufacturer: Merck Sharp & Dohme (UK) Limited [London; UK], United Kingdom

Package Size

90's HDPE Bottle

Price & Supplier

Price in UAE: AED 74317.50

Dosage Information

Adult Dose

120 mg orally once daily, taken with or without food

Pediatric Dose

Safety and efficacy not established in pediatric patients

Side Effects

Fatigue, nausea, diarrhea, headache, hypertension, anemia

Important Warnings

Risk of tumor flare upon discontinuation; monitor for signs of hypertension; may cause fetal harm; not recommended for use in pregnancy or breastfeeding

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. The information presented here is specific to medicines available in UAE pharmacies and is regularly updated to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.

Belzutifan – Uses, Dosage, and Brands in UAE